{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T06:12:36Z","timestamp":1779257556634,"version":"3.51.4"},"reference-count":48,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:00:00Z","timestamp":1779235200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Diffuse alveolar hemorrhage (DAH) is a life-threatening manifestation of ANCA-associated vasculitis (AAV). Data regarding the determinants of in-hospital mortality, particularly the role of specific opportunistic pathogens, remain limited.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Study design and methods<\/jats:title>\n                    <jats:p>\n                      This retrospective cohort study included patients with AAV complicated by DAH admitted to Peking University First Hospital between January 2015 and December 2025. Clinical characteristics, bronchoalveolar lavage fluid (BALF) profiles, microbiological findings, and therapeutic interventions were compared between survivors and non-survivors. Candidate predictors were selected\n                      <jats:italic>a priori<\/jats:italic>\n                      based on clinical relevance and published evidence. Least absolute shrinkage and selection operator (LASSO) regression was employed as a complementary screening tool, and multivariable logistic regression was performed to identify independent risk factors for in-hospital mortality.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 58 patients were enrolled, of whom 13 (22.4%) died during hospitalization. Infection-related septic shock was the predominant cause of death, accounting for 76.9% of fatalities. Pulmonary infection occurred in 60.3% of the cohort and was significantly more frequent among non-survivors (92.3% vs. 51.1%;\n                      <jats:italic>p<\/jats:italic>\n                      \u202f=\u202f0.009). Invasive pulmonary aspergillosis (IPA) was identified in 12.1% of all patients and was markedly more common in non-survivors (46.2% vs. 2.2%;\n                      <jats:italic>p<\/jats:italic>\n                      \u202f&amp;lt;\u202f0.001). On multivariable analysis, a higher baseline age-adjusted Charlson Comorbidity Index (aCCI) (adjusted OR, 2.78; 95% CI, 1.31\u20135.87;\n                      <jats:italic>p<\/jats:italic>\n                      \u202f=\u202f0.007) and the need for early mechanical ventilation (adjusted OR, 14.45; 95% CI, 1.17\u2013179.11;\n                      <jats:italic>p<\/jats:italic>\n                      \u202f=\u202f0.038) remained independently associated with in-hospital mortality.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Among patients with AAV complicated by DAH, in-hospital mortality remains substantial and is predominantly attributable to infection-related septic shock. Higher baseline aCCI and the need for early mechanical ventilation are independent predictors of in-hospital death. The high incidence of IPA may be associated with mortality and underscores the need for heightened clinical vigilance and proactive screening in this profoundly immunocompromised population.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2026.1840399","type":"journal-article","created":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T05:46:41Z","timestamp":1779256001000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical characteristics and predictors of in-hospital mortality in patients with ANCA-associated vasculitis complicated by diffuse alveolar hemorrhage: a retrospective cohort study"],"prefix":"10.3389","volume":"13","author":[{"given":"Xinran","family":"Gao","sequence":"first","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, Peking University First Hospital","place":["Beijing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xi","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, Peking University First Hospital","place":["Beijing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunyao","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, Peking University First Hospital","place":["Beijing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, Peking University First Hospital","place":["Beijing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chengli","family":"Que","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, Peking University First Hospital","place":["Beijing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guangfa","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, Peking University First Hospital","place":["Beijing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, Peking University First Hospital","place":["Beijing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,20]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/art.37715","article-title":"2012 revised international Chapel Hill consensus conference nomenclature of Vasculitides","volume":"65","author":"Jennette","year":"2013","journal-title":"Arthritis Rheum"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/s41572-020-0204-y","article-title":"Anca-associated vasculitis","volume":"6","author":"Kitching","year":"2020","journal-title":"Nat Rev Dis Primers"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"104039","DOI":"10.1016\/j.lpm.2020.104039","article-title":"Lung involvement in ANCA-associated vasculitis","volume":"49","author":"Sacoto","year":"2020","journal-title":"Presse Med"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1378\/chest.08-2084","article-title":"Diffuse alveolar hemorrhage","volume":"137","author":"Lara","year":"2010","journal-title":"Chest"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1002\/art.39562","article-title":"Diffuse alveolar hemorrhage secondary to antineutrophil cytoplasmic antibody-associated vasculitis: predictors of respiratory failure and clinical outcomes","volume":"68","author":"Diaz-Caballero","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1056\/NEJMoa0909905","article-title":"Rituximab versus cyclophosphamide for ANCA-associated vasculitis","volume":"363","author":"Stone","year":"2010","journal-title":"N Engl J Med"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1136\/annrheumdis-2015-208073","article-title":"Clinical outcomes of treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis based on ANCA type","volume":"75","author":"Unizony","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.jaci.2012.05.058","article-title":"Antineutrophil cytoplasmic autoantibodies and myeloperoxidase autoantibodies in clinical expression of Churg-Strauss syndrome","volume":"131","author":"Healy","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.jaut.2013.03.003","article-title":"Long-term outcomes of 118 patients with eosinophilic granulomatosis with polyangiitis (Churg\u2013Strauss syndrome) enrolled in two prospective trials","volume":"43","author":"Samson","year":"2013","journal-title":"J Autoimmun"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1002\/acr2.11263","article-title":"Clinical manifestations and long-term outcomes of eosinophilic granulomatosis with polyangiitis in North America","volume":"3","author":"Doubelt","year":"2021","journal-title":"ACR Open Rheumatol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/S0140-6736(23)01736-1","article-title":"Diagnosis and management of ANCA-associated vasculitis","volume":"403","author":"Kronbichler","year":"2024","journal-title":"Lancet"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1002\/art.41773","article-title":"2021 American College of Rheumatology\/Vasculitis Foundation guideline for the management of antineutrophil cytoplasmic antibody-associated vasculitis","volume":"73","author":"Chung","year":"2021","journal-title":"Arthritis Rheum"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1136\/annrheumdis-2016-209133","article-title":"EULAR\/ERA-EDTA recommendations for the management of ANCA-associated vasculitis","volume":"75","author":"Yates","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"e0196009","DOI":"10.1371\/journal.pone.0196009","article-title":"Effect of plasma exchange on in-hospital mortality in patients with pulmonary hemorrhage secondary to antineutrophil cytoplasmic antibody-associated vasculitis: a propensity-matched analysis using a nationwide administrative database","volume":"13","author":"Uechi","year":"2018","journal-title":"PLoS One"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1164\/rccm.202308-1426OC","article-title":"Alveolar Hemorrhage in antineutrophil cytoplasmic antibody-associated Vasculitis: results of an international randomized controlled trial (PEXIVAS)","volume":"209","author":"Fussner","year":"2024","journal-title":"Am J Respir Crit Care Med"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"811","DOI":"10.55563\/clinexprheumatol\/s9su9e","article-title":"Impact of concurrent glomerulonephritis on outcomes of diffuse alveolar haemorrhage in antineutrophil cytoplasmic antibody-associated vasculitis","volume":"42","author":"Cohen","year":"2024","journal-title":"Clin Exp Rheumatol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"102397","DOI":"10.1016\/j.jaut.2019.102397","article-title":"Alveolar haemorrhage in ANCA-associated vasculitis: long-term outcome and mortality predictors","volume":"108","author":"Quartuccio","year":"2020","journal-title":"J Autoimmun"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"211","DOI":"10.3109\/03009742.2012.754939","article-title":"Long-term outcome of severe alveolar haemorrhage in ANCA-associated vasculitis: a retrospective cohort study","volume":"42","author":"Hruskova","year":"2013","journal-title":"Scand J Rheumatol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s13613-017-0262-9","article-title":"Patients with ANCA-associated vasculitis admitted to the intensive care unit with acute vasculitis manifestations: a retrospective and comparative multicentric study","volume":"7","author":"Demiselle","year":"2017","journal-title":"Ann Intensive Care"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1007\/s00296-025-05812-8","article-title":"ANCA-associated vasculitis and the impact of diffuse alveolar hemorrhage in elderly patients: a retrospective cohort study","volume":"45","author":"Schaier","year":"2025","journal-title":"Rheumatol Int"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"103713","DOI":"10.1016\/j.autrev.2024.103713","article-title":"Characteristics and risk factors for infection in patients with ANCA-associated vasculitis: a systematic review and meta-analysis","volume":"24","author":"Luo","year":"2025","journal-title":"Autoimmun Rev"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1056\/NEJMoa1803537","article-title":"Plasma exchange and glucocorticoids in severe ANCA-associated Vasculitis","volume":"382","author":"Walsh","year":"2020","journal-title":"N Engl J Med"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1016\/j.kint.2021.08.025","article-title":"Combination treatment with rituximab, low-dose cyclophosphamide and plasma exchange for severe antineutrophil cytoplasmic antibody-associated vasculitis","volume":"100","author":"Gulati","year":"2021","journal-title":"Kidney Int"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"410","DOI":"10.3899\/jrheum.191042","article-title":"Clinical characteristics and prognostic analysis of microscopic polyangiitis with diffuse alveolar Hemorrhage","volume":"48","author":"Tang","year":"2021","journal-title":"J Rheumatol"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1159\/000521288","article-title":"Charlson comorbidity index: a critical review of clinimetric properties","volume":"91","author":"Charlson","year":"2022","journal-title":"Psychother Psychosom"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"e152","DOI":"10.1097\/MD.0000000000000152","article-title":"Association of the charlson comorbidity index with renal outcome and all-cause mortality in antineutrophil cytoplasmatic antibody-associated vasculitis","volume":"93","author":"Ofer-Shiber","year":"2014","journal-title":"Medicine (Baltimore)"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1136\/annrheumdis-2021-221796","article-title":"2022 American College of Rheumatology\/European Alliance of associations for rheumatology classification criteria for microscopic polyangiitis","volume":"81","author":"Suppiah","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1097\/01.mlr.0000182534.19832.83","article-title":"Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data","volume":"43","author":"Quan","year":"2005","journal-title":"Med Care"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/0895-4356(94)90129-5","article-title":"Validation of a combined comorbidity index","volume":"47","author":"Charlson","year":"1994","journal-title":"J Clin Epidemiol"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1136\/ard.2008.101279","article-title":"Modification and validation of the Birmingham vasculitis activity score (version 3)","volume":"68","author":"Mukhtyar","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1164\/rccm.202507-1692ST","article-title":"Diagnosis and management of community-acquired pneumonia. An official American Thoracic Society clinical practice guideline","volume":"212","author":"Jones","year":"2026","journal-title":"Am J Respir Crit Care Med"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"e61","DOI":"10.1093\/cid\/ciw353","article-title":"Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society","volume":"63","author":"Kalil","year":"2016","journal-title":"Clin Infect Dis"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.eururo.2024.03.035","article-title":"European Association of Urology guidelines on urological infections: summary of the 2024 guidelines","volume":"86","author":"Kranz","year":"2024","journal-title":"Eur Urol"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"e0013724","DOI":"10.1128\/cmr.00137-24","article-title":"The american society for microbiology\u2019s evidence-based laboratory medicine practice guidelines for the diagnosis of bloodstream infections using rapid tests: a systematic review and meta-analysis","volume":"38","author":"Wolk","year":"2025","journal-title":"Clin Microbiol Rev"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","article-title":"Revision and update of the consensus definitions of invasive fungal disease from the european organization for research and treatment of cancer and the mycoses study group education and research consortium","volume":"71","author":"Donnelly","year":"2020","journal-title":"Clin Infect Dis"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s00134-024-07737-5","article-title":"What intensivists need to know about cytomegalovirus infection in immunocompromised ICU patients","volume":"51","author":"Fern\u00e1ndez","year":"2025","journal-title":"Intensive Care Med"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1053\/j.ajkd.2003.08.015","article-title":"Plasmapheresis therapy for diffuse alveolar hemorrhage in patients with small-vessel vasculitis","volume":"42","author":"Klemmer","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1093\/rheumatology\/keq061","article-title":"Pulmonary haemorrhage in ANCA-associated vasculitis","volume":"49","author":"Ravindran","year":"2010","journal-title":"Rheumatol Oxf Engl"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1097\/MAJ.0b013e3181928d24","article-title":"Severe pulmonary hemorrhage in patients with end-stage renal disease in antineutrophil cytoplasmic autoantibody-associated vasculitis","volume":"337","author":"Chen","year":"2009","journal-title":"Am J Med Sci"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1111\/1744-9987.12939","article-title":"Plasma exchange therapy to reduce mortality in Japanese patients with diffuse alveolar hemorrhage and microscopic polyangiitis","volume":"24","author":"Abe","year":"2020","journal-title":"Ther Apher Dial"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.idc.2023.12.004","article-title":"Management of ventilator-associated pneumonia: guidelines","volume":"38","author":"Metersky","year":"2024","journal-title":"Infect Dis Clin N Am"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"351","DOI":"10.3390\/jcm12010351","article-title":"Predictive factors of cytomegalovirus viremia during the clinical course of anti-neutrophil cytoplasmic antibody (ANCA)-associated Vasculitis: a single Center observational study","volume":"12","author":"Harada","year":"2023","journal-title":"J Clin Med"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1093\/mr\/roaf008","article-title":"Risk factors for cytomegalovirus reactivation during the treatment of ANCA-associated vasculitis: a retrospective cohort study of the J-CANVAS study","volume":"35","author":"Kawamori","year":"2025","journal-title":"Mod Rheumatol"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"3014","DOI":"10.1093\/rheumatology\/keaa070","article-title":"Characterizing infection in anti-neutrophil cytoplasmic antibody-associated vasculitis: results from a longitudinal, matched-cohort data linkage study","volume":"59","author":"Sarica","year":"2020","journal-title":"Rheumatology"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.1093\/rheumatology\/keaa699","article-title":"Incidence and predictors of severe infections in ANCA-associated vasculitis: a population-based cohort study","volume":"60","author":"Rathmann","year":"2021","journal-title":"Rheumatology"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/s41584-018-0145-y","article-title":"Pathogenesis and therapeutic interventions for ANCA-associated vasculitis","volume":"15","author":"Nakazawa","year":"2019","journal-title":"Nat Rev Rheumatol"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1164\/ajrccm.161.2.9904076","article-title":"Activation of neutrophils, eosinophils, and lymphocytes in the lower respiratory tract in Wegener\u2019s granulomatosis","volume":"161","author":"Schnabel","year":"2000","journal-title":"Am J Respir Crit Care Med"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1840399\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T05:46:43Z","timestamp":1779256003000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1840399\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,20]]},"references-count":48,"alternative-id":["10.3389\/fmed.2026.1840399"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1840399","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,20]]},"article-number":"1840399"}}